Hemophilia B is a quasi-quantitative condition with certain mutations showing phenotypic plasticity

Genomics

Volumn 94, Issue 6, 2009, Pages 433-437

  Chavali, Sreenivas ^a   Ghosh, Saurabh ^b   Bharadwaj, Dwaipayan ^a  

^a CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

^b INDIAN STATISTICAL INSTITUTE   (India)

Author keywords

Clotting activity; Continuous trait; Evolutionary conservation; Hemophilia B; Phenotypic plasticity; Prenatal diagnosis

Indexed keywords

ALANINE; ARGININE; ASPARTIC ACID; CYSTEINE; GLUTAMINE; GLYCINE; PHENYLALANINE; PROLINE; SERINE; THREONINE; TRYPTOPHAN; VALINE;

AMINO ACID SUBSTITUTION; ARTICLE; GENE CLUSTER; GENE FREQUENCY; GENE SEQUENCE; GENE STRUCTURE; GENETIC CONSERVATION; GENETIC IDENTIFICATION; HEMOPHILIA B; HUMAN; MISSENSE MUTATION; MUTATIONAL ANALYSIS; PHENOTYPIC PLASTICITY; PHENOTYPIC VARIATION; PRIORITY JOURNAL; STRUCTURE ANALYSIS;

ABORTION, EUGENIC; ALGORITHMS; ALLELES; AMINO ACID SUBSTITUTION; CLUSTER ANALYSIS; CONSERVED SEQUENCE; FACTOR IX; HEMOPHILIA B; HUMANS; MUTATION, MISSENSE; PARTIAL THROMBOPLASTIN TIME; PENETRANCE; PHENOTYPE; PRENATAL DIAGNOSIS; PROTEIN FOLDING; SEVERITY OF ILLNESS INDEX; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 70449091812     PISSN: 08887543     EISSN: 10898646     Source Type: Journal    
DOI: 10.1016/j.ygeno.2009.08.005     Document Type: Article

References (26)

1. Langdell R.D., Wagner R.H., and Brinkhous K.M. Effect of antihemophilic factor on one-stage clotting tests; a presumptive test for hemophilia and a simple one-stage antihemophilic factor assay procedure. J. Lab. Clin. Med. 41 (1953) 637-647
2. Mahajan A., et al. Allelic heterogeneity of molecular events in human coagulation factor IX in Asian Indians. Hum. Mutat. 28 (2007) 526
3. Sharma A., Chavali S., Mahajan A., Biswas P., and Bharadwaj D. Multiple substitutions at single site: interpreting the effect of Asn92 mutations in human coagulation factor IX. Haemophilia 14 (2008) 396-399
4. Chavali S., Sharma A., Tabassum R., and Bharadwaj D. Sequence and structural properties of identical mutations with varying phenotypes in human coagulation factor IX. Proteins 73 (2008) 63-71
5. Giannelli F., et al. Haemophilia B: database of point mutations and short additions and deletions-eighth edition. Nucleic Acids Res. 26 (1998) 265-268
6. E. Gray, D. Sands, A.R. Hubbard, Expert Committee on Biological Standardization: Report on the calibration of the proposed third international standard for factors II, VII, IX, X, plasma (99/826), World Health Organization (2001) (Accessed from www.who.int/entity/bloodproducts/cs/011946.pdf).
7. Badano J.L., and Katsanis N. Beyond Mendel: an evolving view of human genetic disease transmission. Nat. Rev. Genet. 3 (2002) 779-789
8. Khachidze M., et al. Genetic determinants of normal variation in coagulation factor (F) IX levels: genome-wide scan and examination of the FIX structural gene. J. Thromb. Haemost. 4 (2006) 1537-1545
9. Bolton-Maggs P.H., and Pasi K.J. Haemophilias A and B. Lancet 361 (2003) 1801-1809
10. Chandy M. Treatment options in the management of hemophilia in developing countries (2005), World Federation of Hemophilia, Montreal, Canada. http://www.wfh.org (accessed from www.wfh.org)
11. Bottema C.D., et al. Missense mutations and evolutionary conservation of amino acids: evidence that many of the amino acids in factor IX function as "spacer" elements. Am. J. Hum. Genet. 49 (1991) 820-838
12. Valdar W.S. Scoring residue conservation. Proteins 48 (2002) 227-241
13. Sunyaev S.R., et al. PSIC: profile extraction from sequence alignments with position-specific counts of independent observations. Protein Eng. 12 (1999) 387-394
14. Ramensky V., Bork P., and Sunyaev S. Human non-synonymous SNPs: server and survey. Nucleic Acids Res. 30 (2002) 3894-3900
15. Ng P.C., and Henikoff S. SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res. 31 (2003) 3812-3814
16. Stone E.A., and Sidow A. Physicochemical constraint violation by missense substitutions mediates impairment of protein function and disease severity. Genome Res. 15 (2005) 978-986
17. Grantham R. Amino acid difference formula to help explain protein evolution. Science 185 (1974) 862-864
18. Ahmad S., Gromiha M.M., and Sarai A. RVP-net: online prediction of real valued accessible surface area of proteins from single sequences. Bioinformatics 19 (2003) 1849-1851
19. Capriotti E., Fariselli P., and Casadio R. I-Mutant2.0: predicting stability changes upon mutation from the protein sequence or structure. Nucleic Acids Res. 33 (2005) W306-310
20. McGuffin L.J., Bryson K., and Jones D.T. The PSIPRED protein structure prediction server. Bioinformatics 16 (2000) 404-405
21. Li X., Romero P., Rani M., Dunker A.K., and Obradovic Z. Predicting protein disorder for N-, C-, and internal regions. Genome Inform. Ser. Workshop Genome Inform. 10 (1999) 30-40
22. Romero P., et al. Sequence complexity of disordered protein. Proteins 42 (2001) 38-48
23. Sham P.C., and Curtis D. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann. Hum. Genet. 59 (1995) 97-105
24. Yoshitake S., Schach B.G., Foster D.C., Davie E.W., and Kurachi K. Nucleotide sequence of the gene for human factor IX (antihemophilic factor B). Biochemistry 24 (1985) 3736-3750
25. Antonarakis S.E. Recommendations for a nomenclature system for human gene mutations. Nomenclature Working Group. Hum. Mutat. 11 (1998) 1-3
26. Den Dunnen J.T., and Antonarakis S.E. Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum. Mutat. 15 (2000) 7-12